Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Cell Fate and Tissue Structure: Full Evidence Review

Previous related pageVitamin D, Cell Fate and Tissue Structure: Study SummaryNext related pageChildhood Vitamin D, Immune Development and Neurodevelopment: Full Evidence Review
Study at a glance

What question did the studies ask?

Researchers asked whether vitamin D changes how cells develop specialised roles, and whether tissues then work differently. This review compares cell cultures, human colon tissue cultures and animal experiments. Most experiments used calcitriol, the active vitamin D hormone. That differs from taking vitamin D3.

What did the researchers find?

Rat cells that make myelin, the insulation around nerve fibres, matured more under particular culture conditions. Mouse skin experiments linked loss of the vitamin D receptor to changes in early wound repair. The wounds eventually closed. Other experiments found less formation of fat cells from immature cells in mouse muscle. Two human colon-culture studies gave different descriptions of differentiation under different conditions. Very high injected vitamin D3 also produced harmful mineral deposits in mouse blood vessels.

What does this mean?

The results do not support one direction of change in every cell. A changed cell protein or gene signal does not prove a new cell identity. Changes in myelin-associated structure also do not establish how well nerve fibres carry electrical signals. Changes in muscle fat do not establish muscle strength. Removing the receptor is not the same as having low vitamin D intake. These findings explain selected cell responses, but do not show that extra vitamin D repairs tissues in people.

Read the full article below ↓

Vitamin D signalling can change how cells mature, maintain their identity or enter a specialised lineage. The direction varies across experimental models: active vitamin D promotes some maturation responses, inhibits others and can accompany harmful mineralisation. This review asks both what changed in cell fate and whether that change was connected to tissue structure or function. For the shorter account, read Vitamin D, Cell Fate and Tissue Structure: Study Summary.

What counts as a change in cell fate?

Differentiation is the acquisition of specialised cellular features. Lineage commitment is a more specific claim: a progenitor becomes restricted towards one possible cell type. Neither is established simply because cells divide less. A cell may become temporarily quiet, remain capable of several differentiation routes, change a few marker proteins or mature within a lineage it had already entered. These distinctions determine what the experiments below can answer. The broader subject is introduced in Vitamin D and Cell Differentiation.

This is a focused comparison of primary experiments, not a meta-analysis or an exhaustive catalogue of every vitamin D-responsive tissue. The studies use different cells, genetic manipulations, media and endpoints, so their effects cannot responsibly be pooled into one overall differentiation percentage. Cultures, tissue slices, animal experiments and human observations within the same publication are complementary parts of a programme, rather than separate replications. [1] [2] [7] [5] [6] [4] [8]

Most cell experiments used calcitriol, the active vitamin D hormone, often at 100 nanomoles per litre. That is not the same exposure as taking cholecalciferol, or vitamin D3. Removing the vitamin D receptor, abbreviated VDR, is also different from reducing dietary vitamin D. Receptor presence, ligand binding and downstream responses must be distinguished, as explained in Vitamin D Receptors. Experimental concentrations and animal doses describe these studies; they are not personal treatment instructions.

Oligodendrocytes: maturation with a conditional hormone response

De la Fuente and colleagues studied neonatal rat oligodendrocyte progenitors, cells already associated with the lineage that produces myelin, the insulating membrane around nerve fibres. The investigators combined receptor antagonism, gene silencing, receptor-partner assays and tissue-slice experiments. They measured myelin basic protein, a maturation-associated protein, alongside Olig2 lineage staining and Ki67, a proliferation marker. This is stronger than relying on one changed transcript, but does not trace a choice among all neural lineages. [1]

An important null result came first: adding calcitriol to conventional-serum cultures produced no additional differentiation response. After charcoal treatment of serum used during earlier culture, 100 nanomoles per litre calcitriol increased myelin-basic-protein positivity within the Olig2-positive population by 80.1% and reduced Ki67 positivity by 47%. These are relative changes, not percentage-point differences. Charcoal removes other steroids as well, and measurements did not establish that every treated serum was completely free of vitamin D-related material. The contrast therefore shows dependence on the culture environment. [1]

Tissue slices extended the question beyond marker abundance. Receptor antagonism reduced myelin organisation and remyelination measured by overlapping myelin and nerve-fibre staining. At eight days, remyelination was 42% and 48% lower at the two tested antagonist concentrations, 0.2 and 2 micromoles per litre. Because a slice contains several cell types, this result does not isolate every effect to the progenitors. This structural endpoint does not demonstrate restored electrical conduction, behaviour or repair in a person. The small postmortem multiple-sclerosis comparison was additionally limited by major age and sex differences between cases and controls. The distinction between cellular output and integrated renewal is developed in Vitamin D and Regeneration. [1]

Skin: cell output, migration and differentiation change together

Oda and colleagues deleted Vdr in Krt14-associated mouse epidermal cells and their progeny under a low-calcium dietary context. They combined cell-marker measurements, wound experiments and reporter tracing of labelled cellular output. Krt14 marks basal epidermal cells, including stem cells, rather than one purified stem-cell class. Labelled contribution to epidermal structures over 30 days fell, and early wound-cell activation, migration and differentiation were impaired. Human keratinocyte experiments with reduced VDR also showed less migration and lower induced differentiation markers, while basal keratin markers were largely unchanged. [2]

These measurements relate cell behaviour to epidermal organisation. However, the wounds ultimately closed. The experiment does not show permanent failure of healing, and because proliferation, migration and differentiation changed together, it does not isolate differentiation as the sole cause of early repair changes. The tissue setting is covered in Vitamin D and Skin, while Vitamin D and Tissue Repair explains why restoration involves several coordinated processes. [2]

A separate receptor-mutant experiment prevents a nutritional overinterpretation. Skorija and colleagues expressed human VDR variants in the skin of receptor-null mice. A ligand-binding-defective variant restored selected early and later hair-cycle outcomes despite lacking conventional hormone binding and ligand-dependent reporter activation. Another variant gave less complete long-term rescue. Receptor loss therefore cannot be treated simply as vitamin D deprivation, and extra vitamin D is not implied to repair receptor loss. Nor does this show that every skin function is independent of hormone binding. Hairless-partner association was retained, but no selective interface test established it as the sole mediator. [3]

Muscle progenitors: inhibiting one differentiation route

Hosoyama and colleagues studied mouse muscle mesenchymal progenitors, which can contribute to fat accumulation within muscle. Calcitriol inhibited their differentiation towards fat cells during seven days of culture. Removing Vdr from these progenitors abolished that inhibitory response. This provides cell-specific receptor evidence for one differentiation route and contradicts the idea that vitamin D must promote every form of maturation. [4]

RUNX1 protein fell without a corresponding decrease in its messenger RNA, the intermediate copied from a gene before protein production. An altered protein does not automatically establish transcriptional control. No direct VDR: RUNX1 complex or RUNX1 rescue experiment demonstrated a complete exclusive mechanism. The distinction between gene activity and protein abundance connects this result to Vitamin D and Gene Expression. [4]

The animal work measured tissue composition. Dietary deficiency increased muscle fat in older mice but not young mice, and progenitor-specific receptor loss increased fat after tendon-cutting-induced atrophy. Muscle-fibre cross-sectional area did not significantly change; force was not tested. A control without tamoxifen leaves a treatment-control limitation in the conditional model. Human samples from 48 women with osteoarthritis showed an age: muscle-fat association, but their vitamin D blood levels were not measured. This observation cannot establish a vitamin D effect or treatment for weakness. [4]

Human colon organoids: different protocols and endpoints

Two human organoid studies prevent a one-direction account. Organoids are three-dimensional tissue-cell cultures. They reproduce selected epithelial features but not a whole intestine with immune, vascular and stromal inputs. Bustamante-Madrid and colleagues used normal-adjacent tissue from colorectal-cancer patients and tumour organoids. They induced differentiation using BMP4 signalling or inhibition of the Notch pathway, then compared responses to 100 nanomoles per litre calcitriol over 48 or 72 hours. [5]

In normal organoids, calcitriol generally opposed advanced absorptive-cell and mucus-cell differentiation measured through transcripts and ultrastructure. One Notch-inhibitor absorptive-cell result differed from this general direction. Tumour marker transcripts did not significantly change, although some tumour cultures showed limited structural maturation. SMOC2 was proposed as part of the response, but was not selectively established as the mediator. [5]

Blinded electron-microscopy scoring examined absorptive-cell and mucus-cell features, including microvilli and associated rootlet structures, and clusters of secretory granules. These structural measurements go beyond a marker list, but their denominator needs care. Thousands of scored cell profiles came from only three donors and were nested within organoids. Every profile is not an independent person. The pooled categorical analysis did not model that donor and organoid hierarchy. Neither intestinal permeability, absorption nor clinical benefit was measured. Less advanced differentiation cannot therefore be called proven protection against tissue exhaustion. [5]

Kellermann and colleagues cultured organoids from six healthy donors and six people with quiescent ulcerative colitis. The growth experiment used 100 nanomoles per litre calcitriol for ten days, followed by reseeding for ten days without treatment. Growth and later reformation fell in both donor groups, alongside differentiation-associated gene responses. Receptor-edited cultures resisted the response, although these lines had undergone extended selection in calcitriol. Separate short genomic experiments used one donor and a higher concentration of one micromole per litre: DNA-binding measurements after two hours and RNA measurements after six or 24 hours. These were not the ten-day growth protocol, and replicate cultures were not independent people. The endpoints did not demonstrate barrier permeability or remission. [6]

The apparent opposition cannot simply be explained as healthy versus diseased cells: both donor groups in the ulcerative-colitis study responded similarly. That study retained Wnt, R-spondin and Noggin inputs, whereas the other deliberately altered BMP and Notch differentiation signals. Duration and endpoints also differed. Reduced growth and reformation are not identical to advanced ultrastructural maturation. The findings support context dependence but do not identify which protocol difference caused the contrasting interpretations. Regulatory cooperation is the relevant connection to Vitamin D and Transcription Factors. [5] [6]

Vascular mineralisation: differentiation-associated change can be harmful

Han and colleagues examined primary vascular smooth-muscle cells and genetically altered mice. Calcitriol in an osteogenic culture environment increased a bone-associated programme and mineral deposition. Receptor loss and altered RUNX2 function reduced parts of the phenotype. Co-immunoprecipitation in transfected cells supported protein association, but was not purified proof of direct native binding in blood vessels. No lineage tracing established the origin of every mineralising cell. [7]

The mouse model used extraordinarily high injected vitamin D3 exposures: 600,000 or 800,000 international units per kilogram per day for three days. These were toxic experimental conditions, not ordinary supplementation. Systemic calcium and dietary effects complicate interpretation of global receptor deletion. RUNX2-mutant protection despite raised calcium supports a contribution beyond calcium alone, but does not remove every systemic alternative. [7]

Actual vascular mineral is a tissue-structure endpoint, not a measurement of vessel stiffness, flow or cardiovascular events. It illustrates why a bone-associated differentiation programme is not automatically beneficial wherever it occurs. Normal skeletal mineralisation, discussed in Vitamin D and Bone, is a different setting. A shared marker name does not make vascular and bone outcomes interchangeable. [7]

Retained potential and suggested plasticity

Klotz and colleagues exposed human marrow-derived mesenchymal stromal cultures to calcitriol across passages. Growth slowed, but cells retained induced cartilage, fat and bone differentiation capacity. They did not spontaneously become one lineage. This is retained multipotency under the tested conditions, not selective commitment or rejuvenated tissue. Small endpoint-specific donor groups and different accumulated growth histories limit interpretation. No direct tissue-function experiment followed. [8]

A later immune-cell study proposed vitamin D-related T-helper-cell plasticity from expression profiles and computational modelling. Its selected human cord-blood comparison was observational rather than the randomized supplementation effect. Mouse experiments used distinct settings. Without fate tracing, functional cytotoxicity assays or an isolated receptor-specific test, the findings remain an unconfirmed transcriptional phenotype. They do not establish a functionally different immune cell or a tissue benefit. [9]

What the endpoints establish

SettingMeasured changeRemaining inference gap
Oligodendrocyte cultures and slicesMaturation markers and myelin-associated organisationConduction, behaviour and human repair were not tested.
Epidermal receptor deletionEarly wound behaviour and labelled cell outputSeveral processes changed; wounds ultimately closed.
Muscle progenitorsFat-cell differentiation and intramuscular fatForce and a human vitamin D intervention were not measured.
Human colon organoidsProtocol-specific expression, growth and ultrastructureWhole-intestine function and clinical benefit were not established.
Vascular high-exposure modelBone-associated programme and vascular mineralPathological exposure does not predict ordinary supplement effects.

The strongest conclusion is conditional: vitamin D-related signalling participates in cell-state regulation, but direction and consequence depend on lineage, developmental state, surrounding signals and the receptor manipulation. Structural measurements strengthen some cases beyond molecular markers, while selective mediation by differentiation often remains unresolved. A convincing change in one system cannot supply missing functional evidence in another. These representative models support a context-specific conclusion, rather than a universal claim that vitamin D directs cells towards healthier tissue.

Scientific sources

[1] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

[2] Vitamin D Receptor Is Required for Proliferation, Migration, and Differentiation of Epidermal Stem Cells and Progeny during Cutaneous Wound Repair. Oda Y, Hu L, Nguyen T, Fong C, Zhang J, Guo P, Bikle DD. Journal of Investigative Dermatology. 2018;138(11):2423-2431. DOI 10.1016/j.jid.2018.04.033; PMID 29787748; PMCID PMC6903414.

[3] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

[4] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.

[5] Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids. Bustamante-Madrid P, Barbáchano A, Albandea-Rodríguez D, Rodríguez-Cobos J, Rodríguez-Salas N, Prieto I, Burgos A, Martínez de Villarreal J, Real FX, González-Sancho JM, Larriba MJ, Lafarga M, Muñoz A, Fernández-Barral A. Cell death & disease. 2024;15(4):301. DOI 10.1038/s41419-024-06680-z; PMID 38684650; PMCID PMC11058856.

[6] Influence of Vitamin D Receptor Signalling and Vitamin D on Colonic Epithelial Cell Fate Decisions in Ulcerative Colitis. Kellermann L, Hansen SL, Maciag G, Granau AM, Johansen JV, Teves JM, Bressan RB, Pedersen MT, Soendergaard C, Baattrup AM, Hammerhøj A, Riis LB, Gubatan J, Jensen KB, Nielsen OH. Journal of Crohn’s & colitis. 2024;18(10):1672-1689. DOI 10.1093/ecco-jcc/jjae074; PMID 38747639; PMCID PMC11479711.

[7] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

[8] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.

[9] Vitamin D exerts endogenous control over TH2 cell fate and immune plasticity. Fangal VD, Kılıç A, Mirzakhani H, Litonjua AA, Demay MB, Levy BD, Weiss ST. iScience. 2025;28(4):112117. DOI 10.1016/j.isci.2025.112117; PMID 40224021; PMCID PMC11987635.

Related reading

Original sources

Source

Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

[1] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.

Publication details

[1] Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation. de la Fuente AG, Errea O, van Wijngaarden P, Gonzalez GA, Kerninon C, Jarjour AA, Lewis HJ, Jones CA, Nait-Oumesmar B, Zhao C, Huang JK, ffrench-Constant C, Franklin RJ. The Journal of cell biology. 2015;211(5):975-985. DOI 10.1083/jcb.201505119; PMID 26644513; PMCID PMC4674280.

Read more →
Source

Vitamin D Receptor Is Required for Proliferation, Migration, and Differentiation of Epidermal Stem Cells and Progeny during Cutaneous Wound Repair.

Published in Oda Y, Hu L, Nguyen T, Fong C, Zhang J, Guo P, Bikle DD. Journal of Investigative Dermatology (2018).

Publication details

[2] Vitamin D Receptor Is Required for Proliferation, Migration, and Differentiation of Epidermal Stem Cells and Progeny during Cutaneous Wound Repair. Oda Y, Hu L, Nguyen T, Fong C, Zhang J, Guo P, Bikle DD. Journal of Investigative Dermatology. 2018;138(11):2423-2431. DOI 10.1016/j.jid.2018.04.033; PMID 29787748; PMCID PMC6903414.

Read more →
Source

Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.

Published in Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.) (2005).

Publication details

[3] Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis. Skorija K, Cox M, Sisk JM, Dowd DR, MacDonald PN, Thompson CC, Demay MB. Molecular endocrinology (Baltimore, Md.). 2005;19(4):855-862. DOI 10.1210/me.2004-0415; PMID 15591533.

Read more →
Source

Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.

[4] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle.

Publication details

[4] Lack of vitamin D signalling in mesenchymal progenitors causes fatty infiltration in muscle. Hosoyama T, Kawai-Takaishi M, Iida H, Yamamoto Y, Nakamichi Y, Watanabe T, Takemura M, Kato S, Uezumi A, Matsui Y. Journal of cachexia, sarcopenia and muscle. 2024;15(3):907-918. DOI 10.1002/jcsm.13448; PMID 38533539; PMCID PMC11154772.

Read more →
Source

Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids

We also investigated the effects of 1α,25-dihydroxyvitamin D3 (calcitriol) on differentiation.

Publication details

[5] Vitamin D opposes multilineage cell differentiation induced by Notch inhibition and BMP4 pathway activation in human colon organoids. Bustamante-Madrid P, Barbáchano A, Albandea-Rodríguez D, Rodríguez-Cobos J, Rodríguez-Salas N, Prieto I, Burgos A, Martínez de Villarreal J, Real FX, González-Sancho JM, Larriba MJ, Lafarga M, Muñoz A, Fernández-Barral A. Cell death & disease. 2024;15(4):301. DOI 10.1038/s41419-024-06680-z; PMID 38684650; PMCID PMC11058856.

Read more →
Source

Influence of Vitamin D Receptor Signalling and Vitamin D on Colonic Epithelial Cell Fate Decisions in Ulcerative Colitis.

[6] Influence of Vitamin D Receptor Signalling and Vitamin D on Colonic Epithelial Cell Fate Decisions in Ulcerative Colitis.

Publication details

[6] Influence of Vitamin D Receptor Signalling and Vitamin D on Colonic Epithelial Cell Fate Decisions in Ulcerative Colitis. Kellermann L, Hansen SL, Maciag G, Granau AM, Johansen JV, Teves JM, Bressan RB, Pedersen MT, Soendergaard C, Baattrup AM, Hammerhøj A, Riis LB, Gubatan J, Jensen KB, Nielsen OH. Journal of Crohn’s & colitis. 2024;18(10):1672-1689. DOI 10.1093/ecco-jcc/jjae074; PMID 38747639; PMCID PMC11479711.

Read more →
Source

Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification

The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification.

Publication details

[7] Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK, Kato S, Choi JY. PloS one. 2013;8(12):e83584. DOI 10.1371/journal.pone.0083584; PMID 24349534; PMCID PMC3861528.

Read more →
Source

1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent Capacity

We wanted to know if 1,25D3 is able to modulate aging processes on a cellular level in human mesenchymal stem cells (hMSC).

Publication details

[8] 1,25-dihydroxyvitamin D3 treatment delays cellular aging in human mesenchymal stem cells while maintaining their multipotent capacity. Klotz B, Mentrup B, Regensburger M, Zeck S, Schneidereit J, Schupp N, Linden C, Merz C, Ebert R, Jakob F. PloS one. 2012;7(1):e29959. DOI 10.1371/journal.pone.0029959; PMID 22242193; PMCID PMC3252365.

Read more →
Source

Vitamin D exerts endogenous control over TH2 cell fate and immune plasticity.

Published in Fangal VD, Kılıç A, Mirzakhani H, Litonjua AA, Demay MB, Levy BD, Weiss ST. iScience (2025).

Publication details

[9] Vitamin D exerts endogenous control over TH2 cell fate and immune plasticity. Fangal VD, Kılıç A, Mirzakhani H, Litonjua AA, Demay MB, Levy BD, Weiss ST. iScience. 2025;28(4):112117. DOI 10.1016/j.isci.2025.112117; PMID 40224021; PMCID PMC11987635.

Read more →